BN Business News
Business Maps⌕ Search Business News
Add your company to Business Communicator →

Business · 24/03/2021Updated: 10/17/2026 · 1 min read

FDA to Include Quinacrine Hydrochloride on 503B Bulks List for Clinical Need Exemptions

Summary

The FDA is developing a list of bulk drug substances for which there is a clinical need, and has proposed including quinacrine hydrochloride on the list, while excluding bromfenac sodium, mitomycin-C, nepafenac, and hydroxychloroquine sulfate.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights

Business insights →
6

Business · 9/15/2026

World Trade Center Health Program Denies Stroke Petitions

The World Trade Center Health Program Administrator has denied petitions to add stroke to the list of WTC-related health conditions due to insufficient evidence, and therefore will not request a recommendation from the WTC Health Program Scientific/Technical Advisory Committee or publish a proposed rule.

Read summary →

Business · 9/14/2026

CMS Invites Public Comment on Proposed Information Collection

The Centers for Medicare & Medicaid Services (CMS) is seeking public input on its plan to gather information from the public, as required by the Paperwork Reduction Act of 1995, and invites comments on the proposed collection, including its necessity, accuracy, and potential uses of technology to reduce the burden.

Read summary →

Business · 9/14/2026

FDA Submits Collection of Information for OMB Review

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995, as part of its customer/partner customer service satisfaction surveys.

Read summary →